Skip to Content

SEC Filings

Filing date	Form	Description	View
Sep 20, 2019	PRER14A	Proxy soliciting materials. Revised preliminary material	0001193125-19-250054.pdf 0001193125-19-250054.rtf 0001193125-19-250054.xls View HTML
Aug 05, 2019	PREC14A	Preliminary proxy statement containing contested solicitations	0001193125-19-213083.pdf 0001193125-19-213083.rtf 0001193125-19-213083.xls View HTML
Aug 06, 2019	PREC14A	Preliminary proxy statement containing contested solicitations	0000921895-19-002103.pdf 0000921895-19-002103.rtf 0000921895-19-002103.xls View HTML
Mar 05, 2012	POS AM	Post-effective amendment to an S-Type filing	0001047469-12-002107.pdf 0001047469-12-002107.rtf 0001047469-12-002107.xls View HTML
Mar 23, 2012	POS AM	Post-effective amendment to an S-Type filing	0001047469-12-003206.pdf 0001047469-12-003206.rtf 0001047469-12-003206.xls View HTML
Apr 19, 2013	DEF 14A	Official notification to shareholders of matters to be brought to a vote ("Proxy")	0001047469-13-004559.pdf 0001047469-13-004559.rtf 0001047469-13-004559.xls View HTML
Mar 28, 2014	DEF 14A	Official notification to shareholders of matters to be brought to a vote ("Proxy")	0001193125-14-120124.pdf 0001193125-14-120124.rtf 0001193125-14-120124.xls View HTML
Mar 27, 2015	DEF 14A	Official notification to shareholders of matters to be brought to a vote ("Proxy")	0001193125-15-108183.pdf 0001193125-15-108183.rtf 0001193125-15-108183.xls View HTML
Apr 25, 2016	DEF 14A	Official notification to shareholders of matters to be brought to a vote ("Proxy")	0001193125-16-553244.pdf 0001193125-16-553244.rtf 0001193125-16-553244.xls View HTML
Jun 26, 2017	DEF 14A	Official notification to shareholders of matters to be brought to a vote ("Proxy")	0001193125-17-212649.pdf 0001193125-17-212649.rtf 0001193125-17-212649.xls View HTML

Data provided by Kaleidoscope.

Back to top

Merrimack Pharmaceuticals, Inc.
One Broadway, 14th floor
Cambridge, MA 02142
617-720-8606
info@merrimack.com

© 2024 Merrimack Pharmaceuticals.